(24 days)
The SpeqRT ultrasound system is for non-invasive imaging of the human body and is intended for the following applications: Fetal, Abdominal, Pediatric, Musculo-skeletal, Cardiac and Peripheral Vessel. Users must have ultrasound training before using the device. See the attached Indications for Use form for specific imaging modes and applications
The Signostics Ltd SignosRT is a hand-held, diagnostic ultrasound system with an onscreen display. Its purpose is to acquire ultrasound echo data and display it in B-Mode, M-Mode, or Spectral Doppler (PW Doppler) on an LCD display.
The provided text describes the regulatory clearance of the SpeqRT ultrasound system, specifically for an update that includes a new L10 transducer. However, the document does not contain a study that quantitatively proves the device meets specific acceptance criteria in terms of clinical performance or accuracy thresholds.
Instead, the document focuses on demonstrating substantial equivalence to predicate devices and adherence to safety and performance standards through non-clinical testing. It highlights the addition of a new transducer (L10) and associated software/materials updates.
Here's the information that can be extracted from the provided text, and where missing information is noted:
1. A table of acceptance criteria and the reported device performance
The document doesn't explicitly state "acceptance criteria" in the form of quantitative performance thresholds for diagnostic accuracy (e.g., sensitivity, specificity, AUC). Instead, it relies on demonstrating comparable or improved resolution to predicate devices through bench testing and compliance with various safety and performance standards.
| Acceptance Criteria (Implied from substantial equivalence) | Reported Device Performance |
|---|---|
| Imaging Performance | SpeqRT L10 imaging performance and measurement accuracy is described as "substantially equivalent" to S3-5 transducer predicate devices. The measured lateral and axial resolution for the SpeqRT L10 is explicitly stated as "less than the S3-5 transducer and predicates 7.5MHz transducer (K090505)", indicating better image resolution. |
| Measurement Accuracy | SpeqRT L10 measurement accuracy is described as "substantially equivalent" to S3-5 transducer predicate devices. |
| Biocompatibility | New materials for the S3, S3-5, and L10 transducers meet ISO-10993 standards (specifically ISO 10993-5:2009, ISO 10993-10:2002, ISO 10993-10:2010, ISO 10993-12:2007). |
| Electrical Safety | Complies with IEC 60601-1:2005, ES60601-1:2005, IEC 60601-2-37:2007, IEC 60601-1-2:2007. |
| Software Development & Verification | Developed and verified according to IEC 62304:2006. Verification reports, traceability, and risk analysis demonstrate the device operates as intended and risks are mitigated. |
| Mechanical Stress | Drop and push testing per ES60601-1; Mechanical Vibration per JIS Z 0232:2004; Drop Test (to concrete): 1 meter. |
| Environmental | Operating Temperature: 0 to 40°C; Humidity: 20% to 80% RH; Water Resistance: Transducer IPX7 lens, IPX1 probe. |
| Acoustic Output | Both S3-5 and L10 transducers maintain MI and TI to be <1.0 at all times (implied for safety, not a direct performance metric but a constraint). |
| Risk Analysis | ISO-14971 applied, concluding the device is safe for its intended use and does not pose unacceptable risks. |
2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)
This information is not provided in the document. The document refers to "bench tested for imaging performance and measurement accuracy" and "tested by independent laboratories," but does not specify sample sizes for these tests, details on the data (e.g., phantoms, ex-vivo, or in-vivo data), or its provenance.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)
This information is not provided. As the study primarily involves non-clinical bench testing and compliance with standards, there's no mention of human experts establishing ground truth in a clinical context for a "test set."
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
This information is not provided. No clinical studies with expert adjudication are described.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
There is no mention of an MRMC comparative effectiveness study, nor any AI assistance in the context of this device. The device is a diagnostic ultrasound system, not an AI-powered image analysis tool.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
This is not applicable. The device is an ultrasound imaging system, which inherently requires a human operator (sonographer/clinician) for image acquisition and interpretation. It is not an algorithm performing a standalone diagnostic task.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)
The document primarily relies on physical measurement standards and laboratory testing as its "ground truth" for technical performance (e.g., resolution, accuracy of measurements on phantoms). For safety and biocompatibility, the ground truth is defined by the compliance requirements of various ISO and IEC standards. There is no mention of clinical ground truth derived from expert consensus, pathology, or outcomes data.
8. The sample size for the training set
This information is not provided. There is no mention of using a "training set" as the described device is a hardware and software system for image acquisition and display, not a machine learning algorithm that requires a training set.
9. How the ground truth for the training set was established
This information is not provided. As above, there's no mention of a training set.
{0}------------------------------------------------
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized caduceus symbol, which is a staff with two snakes coiled around it, and the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged in a circular pattern around the symbol. The caduceus is black, and the text is also black.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
September 3, 2015
Signostics Limited % Mr. Mark Job Responsible Third Party Official Regulatory Technology Services LLC 1394 25th Street, NW BUFFALO MN 55313
Re: K152250 Trade/Device Name: SpegRT Regulation Number: 21 CFR 892.1550 Regulation Name: Ultrasonic pulsed doppler imaging system Regulatory Class: II Product Code: IYN, IYO, ITX Dated: August 7, 2015 Received: August 10, 2015
Dear Mr. Job:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
{1}------------------------------------------------
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Robert Ochs
Robert Ochs, Ph.D. Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Indications for Use
510(k) Number (if known)
Device Name SpeqRT
Indications for Use (Describe)
The SpeqRT ultrasound system is for non-invasive imaging of the human body and is intended for the following applications: Fetal, Abdominal, Pediatric, Musculo-skeletal, Cardiac and Peripheral Vessel. Users must have ultrasound training before using the device. See the attached Indications for Use form for specific imaging modes and applications
Type of Use (Select one or both, as applicable)
区 Prescription Use (Part 21 CFR 801 Subpart D)
□ Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number.
{3}------------------------------------------------
Indications for Use
| 510(k) Number (if known) | K152250 |
|---|---|
| Device Name | SpeqRT |
510(k) Indications for Use Form
TABLE 1 - SPEQRT INDICATIONS FOR USE FORM
System: SpeqRT Intended Use: Diagnostic ultrasound imaging of the human body as follows:
| Clinical Application | Mode of Operation | |||||||
|---|---|---|---|---|---|---|---|---|
| General(Track I Only) | Specific(Tracks I & III) | B | M | PWD | CWD | ColorDoppler | Combined(Specify) | Other*(Specify) |
| Ophthalmic | Ophthalmic | |||||||
| Fetal Imaging& Other | Fetal | P | P | |||||
| Abdominal | P | P | P | |||||
| Intra-operative (Specify) | ||||||||
| Intra-operative (Neuro) | ||||||||
| Laparoscopic | ||||||||
| Pediatric | P | P | ||||||
| Small Organ (Specify) | ||||||||
| Neonatal Cephalic | ||||||||
| Adult Cephalic | ||||||||
| Trans-rectal | ||||||||
| Trans-vaginal | ||||||||
| Trans-urethral | ||||||||
| Trans-esoph. (non-Card.) | ||||||||
| Musculo-skeletal(Conventional) | P | P | ||||||
| Musculo-skeletal(Superficial) | ||||||||
| Intravascular | ||||||||
| Other (Specify) | ||||||||
| Cardiac | Cardiac Adult | P | P | |||||
| Cardiac Pediatric | P | P | ||||||
| Intravascular (Cardiac) | ||||||||
| Trans-esoph. (Cardiac) | ||||||||
| Intra-cardiac | ||||||||
| Other (Specify) | ||||||||
| PeripheralVessel | Peripheral vessel | P | P | P | ||||
| Other (Specify) |
N= new indication; P= previously cleared by FDA; E= added under Appendix E Additional Comments:
Type of Use (Select one or both, as applicable)
区 Prescription Use (Part 21 CFR 801 Subpart D)
□ Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
{4}------------------------------------------------
Indications for Use
| 510(k) Number (if known) | ||||||||
|---|---|---|---|---|---|---|---|---|
| K152250 | ||||||||
| Device NameSpeqRT | ||||||||
| TABLE 2 - SPEQRT INDICATIONS FOR USE FORM | ||||||||
| System: | SpeqRT | |||||||
| Transducer: | S3 (P03479) | |||||||
| Intended Use: | Diagnostic ultrasound imaging of the human body as follows: | |||||||
| Clinical Application | Mode of Operation | |||||||
| General(Track I Only) | Specific(Tracks I & III) | B | M | PWD | CWD | Color Doppler | Combined (Specify) | Other* (Specify) |
| Ophthalmic | Ophthalmic | |||||||
| Fetal | P | P | ||||||
| Abdominal | P | P | P | |||||
| Intra-operative (Specify) | ||||||||
| Intra-operative (Neuro) | ||||||||
| Laparoscopic | ||||||||
| Pediatric | P | P | ||||||
| Small Organ (Specify) | ||||||||
| Neonatal Cephalic | ||||||||
| Adult Cephalic | ||||||||
| Fetal Imaging& Other | Trans-rectal | |||||||
| Trans-vaginal | ||||||||
| Trans-urethral | ||||||||
| Trans-esoph. (non-Card.) | ||||||||
| Musculo-skeletal(Conventional) | P | P | ||||||
| Musculo-skeletal(Superficial) | ||||||||
| Intravascular | ||||||||
| Other (Specify) | ||||||||
| Cardiac | Cardiac Adult | P | P | |||||
| Cardiac Pediatric | P | P | ||||||
| Intravascular (Cardiac) | ||||||||
| Trans-esoph. (Cardiac) | ||||||||
| Intra-cardiac | ||||||||
| Other (Specify) | ||||||||
| PeripheralVessel | Peripheral vessel | P | P | P | ||||
| Other (Specify) |
N= new indication; P= previously cleared by FDA; E= added under Appendix E Additional Comments:
Type of Use (Select one or both, as applicable)
区 Prescription Use (Part 21 CFR 801 Subpart D)
□ Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
| FORM FDA 3881 (8/14) |
|---|
| ---------------------- |
{5}------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
Form Approved: OMB No. 0910-0120 Expiration Date: January 31, 2017 See PRA Statement below.
Indications for Use
| 510(k) Number (if known) | K152250 |
|---|---|
| -------------------------- | --------- |
Device Name
SpeqRT
TABLE 3 - SPEQRT INDICATIONS FOR USE FORM
System: SpeqRT
Transducer: S3-5 (P03611)
Intended Use: Diagnostic ultrasound imaging of the human body as follows:
| Clinical Application | Mode of Operation | |||||||
|---|---|---|---|---|---|---|---|---|
| B | M | PWD | CWD | ColorDoppler | Combined(Specify) | Other*(Specify) | ||
| General(Track I Only) | Specific(Tracks I & III) | |||||||
| Ophthalmic | ||||||||
| Ophthalmic | Ophthalmic | |||||||
| Fetal | P | P | ||||||
| Abdominal | P | P | P | |||||
| Intra-operative (Specify) | ||||||||
| Intra-operative (Neuro) | ||||||||
| Laparoscopic | ||||||||
| Pediatric | P | P | ||||||
| Small Organ (Specify) | ||||||||
| Neonatal Cephalic | ||||||||
| Adult Cephalic | ||||||||
| Fetal Imaging& Other | Trans-rectal | |||||||
| Trans-vaginal | ||||||||
| Trans-urethral | ||||||||
| Trans-esoph. (non-Card.) | ||||||||
| Musculo-skeletal(Conventional) | P | P | ||||||
| Musculo-skeletal(Superficial) | ||||||||
| Intravascular | ||||||||
| Other (Specify) | ||||||||
| Cardiac Adult | P | P | ||||||
| Cardiac | Cardiac Pediatric | P | P | |||||
| Intravascular (Cardiac) | ||||||||
| Trans-esoph. (Cardiac) | ||||||||
| Intra-cardiac | ||||||||
| Other (Specify) | ||||||||
| PeripheralVessel | Peripheral vessel | P | P | P | ||||
| Other (Specify) |
N= new indication; P= previously cleared by FDA; E= added under Appendix E Additional Comments:
Type of Use (Select one or both, as applicable)
区 Prescription Use (Part 21 CFR 801 Subpart D)
□ Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
FORM FDA 3881 (8/14)
{6}------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
Form Approved: OMB No. 0910-0120 Expiration Date: January 31, 2017 See PRA Statement below.
Indications for Use
510(k) Number (if known) K152250 Device Name SpegRT TABLE 4 - SPEQRT INDICATIONS FOR USE FORM System: SpeqRT Transducer: L10 (P04000) Intended Use: Diagnostic ultrasound imaging of the human body as follows: Clinical Application Mode of Operation General Specific M PWD CWD Combined Other* B Color (Track I Only) (Tracks I & III) Doppler (Specify) (Specify) Ophthalmic Ophthalmic Fetal Abdominal Intra-operative (Specify) Intra-operative (Neuro) Laparoscopic Pediatric N N Small Organ (Specify) Neonatal Cephalic Adult Cephalic Fetal Imaging Trans-rectal & Other Trans-vaginal Trans-urethral Trans-esoph. (non-Card.) Musculo-skeletal N N (Conventional) Musculo-skeletal (Superficial) Intravascular Other (Specify) Cardiac Adult Cardiac Pediatric Cardiac Intravascular (Cardiac) Trans-esoph. (Cardiac) Intra-cardiac Other (Specify) Peripheral Peripheral vessel N N N Vessel Other (Specify)
N= new indication; P= previously cleared by FDA; E= added under Appendix E Additional Comments:
Type of Use (Select one or both, as applicable)
区 Prescription Use (Part 21 CFR 801 Subpart D)
□ Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
{7}------------------------------------------------
510(k) Summary
1. Sponsor:
Signostics Ltd PO Box 1048, Pasadena 1284 South Road Clovelly Park, SA 5042 Australia
2. Contact Person: Stewart Bartlett Chief Operating Officer Telephone: +61 (8) 7424 0600
-
- Date Prepared: June 30, 2015
-
- Device Name: SpeqRT
-
- Proprietary/Marketed Names: SignosRT, SONIMAGE P3
6. Common/Usual Name:
Diagnostic ultrasound transducer
7. Classification
Regulatory Class: II
Review Category: Tier II
| Ultrasonic Pulsed Echo Imaging System | (21 CFR 892.1560, 90-IYO) |
|---|---|
| Ultrasonic Pulsed Doppler Imaging System | (21 CFR 892.1550, 90-IYN) |
| Diagnostic Ultrasound Transducer | (21 CFR 892.1570, 90-ITX) |
Classification Panel: Radiology
8. Predicate Devices
SpeqRT Ultrasound System (K130659): This 510k is submitted due to a significant change to SpeqRT Ultrasound System (K130659), for the addition of a new transducer (L10).
Speq Ultrasound System (K090505): contains a 7.5MHz transducer, and therefore is used as a predicate for the new L10 transducer introduced in this application.
{8}------------------------------------------------
9. Risk Analysis Method Used
Signostics Ltd applied ISO-14971 to the design and development of the SignosRT and the change to include the L10 transducer. The conclusion from the risk analysis was the device was safe for its intended use and does not pose any unacceptable risks.
10. Basis for Substantial Equivalence
This submission is for a significant change to the SpeqRT system described in K130659.
The changes are as follows:
- a. A new transducer (L10) is included. The new transducer is a high frequency transducer with a flat transducer surface for providing better superficial resolution and better ergonomics for imaging blood vessels. Note: There are no new indications for use included in the system.
- b. The software has been updated to v2.11.0. The significant changes to the software are to support the new L10 transducer.
- c. The user manual has been updated to v2.11.0 to add the new L10 transducer.
- d. A new packaging box has been created to ship the L10 transducer separate to the main system.
- The previously cleared S3 and S3-5 transducer have been updated to provide a e. more robust transducer lens. The previously cleared transducer contained two patient contact materials, a lens made from blue TPX-MED18, and a body made from white Cycoloy HC1204HF. The updated S3 and S3-5 transducer design contains a single lens and body made from white TPX-MED18 (same as new L10). The ISO-10993 tests have been repeated for the new material.
Excluding the above changes, the previously cleared SpeqRT (K130659) and the new device are identical and unchanged. They transmit ultrasonic energy into patients, then process received echoes to produce on-screen images of anatomy. The indication for use statement of the SignosRT L10 transducer is a subset of the indications for use of the SignosRT S3-5 transducer.
The base SpeqRT system is identical in construction, materials, and controls to the previously cleared SpeqRT (K130659). The patient contact materials have been updated and retested to ISO-10993. The new L10 transducer operating frequency (7-10MHz) is higher than the S3-5 transducer operating frequency (3-5MHz), therefore providing better superficial resolution. Both systems contain sector transducers with annular (circular) acoustic elements generating pie shaped images. Both transducers maintain MI and TI to be <1.0 at all times.
{9}------------------------------------------------
11. Device Description
The Signostics Ltd SignosRT is a hand-held, diagnostic ultrasound system with an onscreen display. Its purpose is to acquire ultrasound echo data and display it in B-Mode, M-Mode, or Spectral Doppler (PW Doppler) on an LCD display.
Technical specifications for the Signostics SignosRT are unchanged after adding the L10 transducer and are as follows:
| System | |||||
|---|---|---|---|---|---|
| Transducer frequencies: | 3MHz (S3 transducer), 3-5MHz (S3-5 transducer) and 10MHz(L10 transducer) | ||||
| Frame rate: | 8Fps or 16Fps (Imaging only) | ||||
| Ultrasound lines/frame: | 128 lines for 90° frame | ||||
| Fields of View: | 1-18 cm for 3MHz and 3-5MHz, 0-6cm for 10MHz | ||||
| External Video Output: | No | ||||
| Liquid-Crystal Display: | 18 bit, 262,000 Color, Active Matrix TFT LCD | ||||
| Materials | Sabic Cycoloy HC1204HF, Mitsui TPX-MED18, Sabic Versollen OMX1255NX-1 | ||||
| Size: - | |||||
| Width: | 6.8 cm | ||||
| Height: | 11.5 cm | ||||
| Depth: | 2.0 cm | ||||
| Weight: | 0.13 kg | ||||
| Electrical | |||||
| External Power: | Input: | 100-240 VAC,50-60Hz | Output: | 5 VDC @ 2A | |
| Battery: | Li-Ion battery pack (2 Whr) | ||||
| Leakage Current: | 10 $ μ $ A maximum | ||||
| Primary Breakdown Voltage: | 3000VAC | ||||
| Safety Standards: | IEC 60601-1:2005, ES60601-1:2005, IEC 60601-2-37:2007, IEC 60601-1-2:2007, ISO 10993-1:2003 | ||||
| Protection Class: | Class II: per IEC 60601-1 | ||||
| Degree of Protection: | Type BF: per IEC 60601-1 |
| Environmental | |
|---|---|
| Mechanical Shock : | Drop and push testing per ES60601-1 |
| Mechanical Vibration: | Random Acceleration Profile per JIS Z 0232:2004 5Hz-300Hz |
| Drop Test (to concrete): | 1 meter |
| Operating Temperature: | 0 to 40°C |
| Humidity: | 20% to 80% RH, non-condensing |
| Water Resistance: | Transducer IPX7 lens, IPX1 probe degree of protection against |
| water | |
| Altitude: | 0.7 - 1.05 standard atmospheres (2500m or 8200 feet) operating |
| Storage | |
| Temperature: | -20 to 45°C |
| Humidity: | 10 to 90% RH, non-condensing |
| Altitude: | 0.5 - 1.05 standard atmospheres storage |
{10}------------------------------------------------
12. Non-clinical Performance Data
Signostics Ltd is applying FDA recognised standards as detailed in the tables above to evaluate the safety of the SpeqRT.
The new SpeqRT L10 transducer has been bench tested for imaging performance and measurement accuracy, with tests showing the SpeqRT L10 imaging performance and measurement accuracy to be substantially equivalent to the S3-5 transducer predicate devices. The measured lateral and axial resolution for the SpeqRT L10 is less than the S3-5 transducer and predicates 7.5MHz transducer (K090505), therefore providing better image resolution.
The SpeqRT L10 transducer has been tested by independent laboratories in conjunction with the SpeqRT system to IEC 60601-1:2005, IEC 60601-2-37:2007, IEC 60601-1-2:2007, ISO 10993-5:2009, ISO 10993-10:2002, ISO 10993-10:2010, ISO 10993-12:2007, NEMA UD-2-2004 (R2009), NEMA UD-3-2004(R2009) and found to comply with all standards.
The software and firmware in the SpeqRT has been developed and verified according to IEC 62304:2006. The verification reports (Appendix R and V), traceability (Appendix O). and risk analysis (Appendix A) demonstrate the SpeaRT operates as intended with the L10 transducer and risks mitigated in firmware have been verified.
The conclusion from the testing is the device is safe and effective for its intended use, and performs as well or better than the predicate devices.
§ 892.1550 Ultrasonic pulsed doppler imaging system.
(a)
Identification. An ultrasonic pulsed doppler imaging system is a device that combines the features of continuous wave doppler-effect technology with pulsed-echo effect technology and is intended to determine stationary body tissue characteristics, such as depth or location of tissue interfaces or dynamic tissue characteristics such as velocity of blood or tissue motion. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.